Published October 10, 2021 | Version v1
Dataset Open

Viral suppression after transition from nonnucleoside reverse transcriptase inhibitor- to dolutegravir-based antiretroviral therapy: A prospective cohort study in Lesotho (DO-REAL study)

Authors/Creators

  • 1. (1) Clinical Research Unit, Department of Medicine, Swiss Tropical and Public Health Institute, Basel, Switzerland (2) Molecular Virology Group, Department of Biomedicine, University of Basel, Basel, Switzerland (3) University of Basel, Basel, Switzerland
  • 2. (4) SolidarMed, Partnerships for Health, Maseru, Lesotho
  • 3. (2) Molecular Virology Group, Department of Biomedicine, University of Basel, Basel, Switzerland (3) University of Basel, Basel, Switzerland
  • 4. (1) Clinical Research Unit, Department of Medicine, Swiss Tropical and Public Health Institute, Basel, Switzerland (3) University of Basel, Basel, Switzerland (5) Department of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland
  • 5. (1) Clinical Research Unit, Department of Medicine, Swiss Tropical and Public Health Institute, Basel, Switzerland (3) University of Basel, Basel, Switzerland
  • 6. (2) Molecular Virology Group, Department of Biomedicine, University of Basel, Basel, Switzerland (3) University of Basel, Basel, Switzerland

Description

Pseudonymized dataset for the published manuscript "Viral suppression after transition from nonnucleoside reverse transcriptase inhibitor- to dolutegravir-based antiretroviral therapy: A prospective cohort study in Lesotho (DO-REAL study)"

Files

Files (284.1 kB)

Name Size Download all
md5:b6b7d470015c0b9387869b6c4c6786ba
284.1 kB Download